The Highest Ranked Digital Platform for Biopharma Is…

The Highest Ranked Digital Platform for Biopharma Is…


At Adnexi we recently completed a survey of healthcare providers to understand the influence and credibility of Digital Opinion Leaders (DOLs). DOLs are experts in the disease who actively share relevant content and participate in digital platforms. DOLs have cultivated an online presence, regularly create relevant content, and engage patients and other healthcare providers.

This time around, we asked the following question:

Which digital platform is most useful for digital content about medical conditions?

?We gave survey respondents a few options to choose from which included:?

·????? Instagram

·????? Facebook

·????? TikTok

·????? X

?·????? YouTube

·????? LinkedIn?

Eighty survey respondents provide their opinions. And the The Highest Ranked Digital Platform for Biopharma Is...

YouTube

YouTube was ranked by healthcare providers to have the best content when it comes to explaining diseases and treatments.

Adnexi is a Solution for Finding & Tracking DOLs

At Adnexi we use advanced search algorithms, multi-language processing, and data aggregation features to locate Digital Opinion Leaders (DOLs) from all over the world, regardless of the languages they use. By bringing together these influential individuals in a single platform, it simplifies the task of discovering, interacting with and collaborating with them. This makes it an invaluable tool for those who want to harness the potential of digital influence on a global level.

We build detailed DOL profiles that report on all channels in use and track digital activity. Any day that a tracked DOL posts new content, your team receives an alert with a link to the content.

We would love to help your biopharma company find the Digital Opinion Leaders that can accelerate drug development and launch.

If you're interested in learning more, please contact:

Sandra Shpilberg

Email: [email protected]

Book a meeting: https://calendly.com/adnexi/30min

要查看或添加评论,请登录

Sandra Shpilberg的更多文章

社区洞察

其他会员也浏览了